Bo Jin

Bo Jin

Auto-generated profile, based on publicly available information

Bo Jin

Senior Department of Hepatology, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZLZHENG LU
ZHENG LU
XSXiaotian Sun
Xiaotian Sun
JHJingjing Han
Jingjing Han
BJBo Jin
Bo Jin
WZWenhui Zhang
Wenhui Zhang
HLHanwei Li
Hanwei Li
Upper gastrointestinal bleeding (UGIB) is common in liver cirrhosis. Although esophageal and gastric varices (EGV) is the main bleeding source, there were still a proportion of patients with peptic ulcer bleeding. Thus, this study aimed to analyze the characteristic of variceal bleeding and peptic ulcer bleeding in liver cirrhosis. Cirrhotic patients with confirmed UGIB by urgent endoscopy from July 2012 to June 2018 were enrolled, and classified into peptic ulcer bleeding group (n = 248) and variceal bleeding group (n = 402). Clinical and endoscopic characteristics, therapeutic efficacy and prognosis were evaluated, and independent risk factors for 42-day morality were determined. The mean age and gender ratio of peptic ulcer bleeding group were higher than those in variceal bleeding group (55.58 ± 11.37 vs. 52.87 ± 11.57, P < 0.01; 4.51:1 vs. 2.87:1, P = 0.023). Variceal bleeding group most commonly presented as red blood emesis and coffee grounds (67.16%), while peptic ulcer group primarily manifested as melena (62.10%). Hepatocellular carcinoma was more prevalent in peptic ulcer group (141 vs. 119, P < 0.01). Albumin level in variceal bleeding group was lower higher (P < 0.01), but serum bilirubin, creatinine and prothrombin time were significantly higher (all P < 0.01). Success rate of endoscopic hemostasis for variceal bleeding and peptic ulcer bleeding was 89.05% and 94.35% (P = 0.021). Univariate and multivariate analysis identified prothrombin time (P = 0.041, OR [95% CI] 0.884 [0.786–0.995]), MELD score (P = 0.000, OR [95% CI] 1.153 [1.073–1.240]), emergency intervention (P = 0.002, OR [95% CI] 8.656 [2.219–33.764]), hepatic encephalopathy before bleeding (P = 0.003, OR [95% CI] 8.119 [2.084–31.637]) and hepatic renal syndrome before bleeding (P = 0.029, OR [95% CI] 3.877 [1.152–13.045]) as the independent predictors for 42-day mortality. Peptic ulcer bleeding should be distinguished from variceal bleeding by clinical and endoscopic characteristics.

12 August 2020 in Virulence
Verified
Journal Article
Open access
YGYinjie Gao
Yinjie Gao
XMXuemei Ma
Xuemei Ma
JBJingfeng Bi
Jingfeng Bi
JCJindong Chu
Jindong Chu
BLBo Liu
Bo Liu
BJBo Jin
Bo Jin
Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread from the early epicenter, Wuhan, to the rest of China, the virulence of SARS-CoV-2 might have evolved at different phases of the pandemic. We therefore compared the unique features among 62 coronavirus disease 2019 (COVID-19) inpatients who contracted SARS-CoV-2 in Wuhan (15 cases), exposed to the patients from Wuhan (26 cases), or acquired the disease without exposure to Wuhan patients (21 cases). Median incubation periods are 4.5 days (3–5) for Wuhan patients, 8 days (3–11) for those infected by Wuhan patients, and 12 days (7–13) for those without aforementioned experience. The disease onset dates are earliest for Wuhan patients and latest for those without exposure to Wuhan patients. Blood lymphocytes were lowest in Wuhan patients, lower in those affected by Wuhan patients, and modest reduced in remaining ones. Disease severity is worst for Wuhan patients, and modest for those without contact with Wuhan patients. Wuhan patients had longest (27 days, 18–28), those transmitted by Wuhan patients had intermediate (16 days, 8–23), and the rest of the patients had shortest (13 days, 8.5–22.5) hospital stay. Early viral exposure, older age, lymphocytopenia, and underlying conditions are risk factors which warrant aggressive intervention. Even though the virulence of SARS-CoV-2 appears decline over the course of serial transmissions, viral testing, contact tracing, social distancing, and face masking should be imposed on general public to contain viral dissemination from both symptomatic and asymptomatic patients with this highly contagious disease.

9 September 2023 in Arab Journal of Gastroenterology
Verified
Journal Article
Closed access
JCJindong Chu
Jindong Chu
ZLZheng Lu
Zheng Lu
CCChunsheng Chi
Chunsheng Chi
WZWenhui Zhang
Wenhui Zhang
QBQian Bi
Qian Bi
BJBo Jin
Bo Jin

8 February 2024 in iLIVER
Verified
Journal Article
Open access
LHLin Han
Lin Han
HXHuan Xie
Huan Xie
XMXue-Mei Ma
Xue-Mei Ma
XLXiao-Long Lu
Xiao-Long Lu
JZJun Zhao
Jun Zhao
YSYing Sun
Ying Sun
Esophagogastric varices (EGV) are common complications of primary biliary cholangitis (PBC). We examined the risk factors for variceal bleeding-related liver transplantation (LT) or death. This prospective observational cohort study involved PBC in our hospital from 1 January 2005 to 1 January 2020. The clinical endpoints were variceal bleeding-related LT and death. Survival analysis was performed using the Kaplan–Meier estimate, cox regression analysis was performed to investigate risk factors. PBC with EGV had significantly shorter survival than those without (p = 0.002). Endoscopic prophylaxis significantly improved poor outcomes in PBC with EGV (p < 0.001). Risk factors in patients with EGV included: cholinesterase (CHE) of 1.2 × ULN at baseline, total bilirubin of >1.2 × ULN, aspartate aminotransferase (AST) of >2.3 × ULN after 1 year of ursodeoxycholic acid (UDCA) treatment, non-biochemical responders according to the Paris criteria, and no history of endoscopic therapy. In PBC without EGV, risk factors included AST of >2.3 × ULN, INR of >1.2 × ULN at baseline, CHE of 1.125. This study provides evidence that AST, INR and CHE are major risk factors for variceal bleeding-related poor outcomes in PBC. For PBC with EGV, a good biochemical response to UDCA and endoscopic prophylaxis may improve survival. These findings can aid for guiding initial PBC risk stratification and screening endoscopy in patients without EGV.

8 September 2020
Verified
Book Chapter
Closed access
PDF file
SQShirui Qi
Shirui Qi
ZWZhongyin Wu
Zhongyin Wu
HJHeyue Jia
Heyue Jia
BJBo Jin
Bo Jin
HLHui Li
Hui Li
GSGang Sun
Gang Sun